Clinical Trials on Refraktärt uroteliala karcinom in China
Totalt 5613 resultat
-
Shanghai Zhongshan HospitalOkändHepatocellulärt karcinomKina
-
RenJi HospitalCARsgen Therapeutics Co., Ltd.AvslutadHepatocellulärt karcinomKina
-
Beijing YouAn HospitalOkändHepatocellulärt karcinomKina
-
Beijing YouAn HospitalOkändHepatocellulärt karcinomKina
-
Tianjin Medical University Cancer Institute and...OkändHepatocellulärt karcinomKina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.OkändHepatocellulärt karcinomKina
-
Peking University Cancer Hospital & InstituteJiangsu HengRui Medicine Co., Ltd.OkändHepatocellulärt karcinomKina
-
Eastern Hepatobiliary Surgery HospitalAvslutadHepatocellulärt karcinomKina
-
Tianjin Medical University Cancer Institute and...Fudan University; Shanghai Zhongshan Hospital; Harbin Medical University; Liaoning... och andra samarbetspartnersOkänd
-
Chinese PLA General HospitalAvslutad
-
Peking Union Medical College HospitalOkändHepatocellulärt karcinomKina
-
Eastern Hepatobiliary Surgery HospitalAvslutadHepatocellulärt karcinomKina
-
Fudan UniversityOkänd
-
Fudan UniversityOkändHepatocellulärt karcinomKina
-
Fudan UniversityOkändHepatocellulärt karcinomKina
-
Eastern Hepatobiliary Surgery HospitalAvslutadHepatocellular Carcinoma; | Radical Hepatic Resection;Kina
-
RenJi HospitalRekryteringLevertransplantation; Komplikationer | Hepatocellulärt karcinom återkommandeKina
-
RenJi HospitalRekryteringLevertransplantation; Komplikationer | Hepatocellulärt karcinom återkommandeKina
-
Yingbin Liu, MD, PhD, FACSThe First Hospital of Jilin University; The First Affiliated Hospital of... och andra samarbetspartnersOkänd
-
RenJi HospitalRekryteringLevertransplantation; Komplikationer | LeverkarcinomKina
-
Guiyang Medical UniversityHar inte rekryterat ännuSkivepitelcancer i huvud och nackeKina
-
Peking UniversityAvslutad
-
Peking UniversityOkändNeuroendokrint karcinomKina
-
Guangxi Medical UniversityOkändHepatocellulärt karcinomKina
-
Henan Cancer HospitalRekrytering
-
Second Affiliated Hospital of Guangzhou Medical...RekryteringHepatocellulärt karcinom Ej resektabeltKina
-
Sun Yat-sen UniversityIndragenAvancerat hepatocellulärt karcinomKina
-
Sun Yat-sen UniversityRekryteringAvancerat hepatocellulärt karcinom | Bevacizumab | Anti-PD1/PDL1-antikroppKina
-
Guangxi Medical UniversityRekrytering
-
Shanghai Zhongshan HospitalHar inte rekryterat ännuHepatocellulärt karcinomKina
-
Peking Union Medical College HospitalRekryteringKombination av Cardonizumab-injektion och TKI Second Line-terapi för avancerad hepatocellulär cancerHepatocellulärt karcinomKina
-
Huashan HospitalRekryteringHepatocellulärt karcinomKina
-
Tianjin Third Central HospitalBGI, ChinaRekryteringHepatocellulärt karcinomKina
-
Biocity Biopharmaceutics Co., Ltd.Har inte rekryterat ännuHepatocellulärt karcinomKina
-
Shanghai Zhongshan HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Har inte rekryterat ännu
-
Shanghai Zhongshan HospitalTakedaRekrytering
-
Beijing YouAn HospitalBeijing Gene Key Life Technology Co., Ltd.Rekrytering
-
Peking Union Medical College HospitalRekrytering
-
Peking Union Medical College HospitalBeijing Immupeutics Medicine Technology LimitedRekryteringHepatocellulärt karcinomKina
-
Beijing Tsinghua Chang Gung HospitalRekrytering
-
Tianjin Medical University Cancer Institute and...RekryteringHepatocellulärt karcinomKina
-
Shanghai Zhongshan HospitalRekryteringHepatocellulärt karcinomKina
-
Shanghai Zhongshan HospitalRekrytering
-
Southwest Hospital, ChinaRekryteringHepatocellulärt karcinomKina
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.RekryteringHepatocellulärt karcinomKina
-
Beijing 302 HospitalShenzhen Third People's Hospital; The first People's Hospital of ZhengzhouRekryteringHepatocellulärt karcinomKina
-
Beijing 302 HospitalLion TCR Pte. Ltd.Rekrytering
-
Eastern Hepatobiliary Surgery HospitalAktiv, inte rekryterandeHepatocellulärt karcinomKina
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Upphängd
-
Shanghai Zhongshan HospitalAnmälan via inbjudanHepatocellulärt karcinomKina